These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11074958)

  • 21. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy.
    Griffiths F; Convery B
    Br J Gen Pract; 1995 Jul; 45(396):355-8. PubMed ID: 7612339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial.
    Buster JE; Kingsberg SA; Aguirre O; Brown C; Breaux JG; Buch A; Rodenberg CA; Wekselman K; Casson P
    Obstet Gynecol; 2005 May; 105(5 Pt 1):944-52. PubMed ID: 15863529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study.
    Glaser RL; Dimitrakakis C
    Maturitas; 2013 Dec; 76(4):342-9. PubMed ID: 24028858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
    Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone and the aging male: to treat or not to treat?
    Bain J
    Maturitas; 2010 May; 66(1):16-22. PubMed ID: 20153946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women awaiting hysterectomy: a qualitative study of issues involved in decisions about oophorectomy.
    Bhavnani V; Clarke A
    BJOG; 2003 Feb; 110(2):168-74. PubMed ID: 12618161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LEI (Lack of tEstosterone Impact) survey in a clinical sample with surgical menopause.
    Nappi RE; Lello S; Melis GB; Albani F; Polatti F; Genazzani AR
    Climacteric; 2009 Dec; 12(6):533-40. PubMed ID: 19905905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Androgen treatment in women.
    Davis SR
    Med J Aust; 1999 Jun; 170(11):545-9. PubMed ID: 10397047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of estradiol versus estradiol and testosterone on brain-activation patterns in postmenopausal women.
    Archer JS; Love-Geffen TE; Herbst-Damm KL; Swinney DA; Chang JR
    Menopause; 2006; 13(3):528-37. PubMed ID: 16735951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic oophorectomy at elective hysterectomy. Effects on psychological well-being at 1-year follow-up and its correlations to sexuality.
    Aziz A; Bergquist C; Nordholm L; Möller A; Silfverstolpe G
    Maturitas; 2005 Aug; 51(4):349-57. PubMed ID: 16039407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Androgen replacement for women.
    Basson R
    Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' outlook, experience, and satisfaction with hysterectomy, bilateral oophorectomy, and subsequent continuation of hormone replacement therapy.
    Khastgir G; Studd J
    Am J Obstet Gynecol; 2000 Dec; 183(6):1427-33. PubMed ID: 11120506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oophorectomy in premenopausal women: health-related quality of life and sexual functioning.
    Teplin V; Vittinghoff E; Lin F; Learman LA; Richter HE; Kuppermann M
    Obstet Gynecol; 2007 Feb; 109(2 Pt 1):347-54. PubMed ID: 17267835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Androgen therapy in women, beyond libido.
    Davis SR
    Climacteric; 2013 Aug; 16 Suppl 1():18-24. PubMed ID: 23647457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Opioid-induced hypogonadism: why and how to treat it.
    De Maddalena C; Bellini M; Berra M; Meriggiola MC; Aloisi AM
    Pain Physician; 2012 Jul; 15(3 Suppl):ES111-8. PubMed ID: 22786450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy.
    Aziz A; Bergquist C; Brännström M; Nordholm L; Silfverstolpe G
    Acta Obstet Gynecol Scand; 2005 Sep; 84(9):854-9. PubMed ID: 16097975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do women with impaired sexual function following oophorectomy benefit from transdermal testosterone at a physiologic dose?
    Reynolds PL
    J Fam Pract; 2000 Dec; 49(12):1148. PubMed ID: 11132065
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety of testosterone use in women.
    Shufelt CL; Braunstein GD
    Maturitas; 2009 May; 63(1):63-6. PubMed ID: 19250779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does retention of the ovaries improve long-term survival after hysterectomy? Prophylactic oophorectomy.
    Studd J
    Climacteric; 2006 Jun; 9(3):164-6. PubMed ID: 16766429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.